4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0001209191-23-045263
CIK 0001671584other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 8:41 AM ET
Size
11.0 KB
Accession
0001209191-23-045263
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2023-08-08+1,833→ 26,504 total - Exercise/Conversion
Restricted Stock Unit
2023-08-08−1,833→ 3,667 total→ Common Stock (1,833 underlying) - Exercise/Conversion
Common Stock
2023-08-08+11,979→ 24,671 total - Exercise/Conversion
Restricted Stock Unit
2023-08-08−11,979→ 11,979 total→ Common Stock (11,979 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
- [F3]On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 8:41 AM ET
- Size
- 11.0 KB